Follow these guidelinesLinks to an external site. when completing each component of the assignment. Contact your course faculty if you have questions.

General Instructions

Explore current literature and clinical practice guidelines to complete the clinical treatment protocol template.

Complete the protocol outline template Download protocol outline templateOpen this document with ReadSpeaker docReaderto develop a protocol for asthma treatment. Use of the template is required. A 10% deduction will be applied if the template is not used. See the rubric.
1. Sections 1-5 on the template have already been completed. You are to complete sections 6-9 and References.
Provide references for your protocol at the bottom of the form where indicated. References should come from the following sources:
1. Asthma Clinical Practice GuidelineLinks to an external site.Open this document with ReadSpeaker docReader
2. Course Textbook (for individual medication information)
3. Journal Articles from within the last five years as defined by program expectationsLinks to an external site..
Follow APA grammar, spelling, word usage, and punctuation rules consistent with formal, scholarly writing.
No more than one short direct quote (15 words or less) may be used in this assignment.
First person should not be used within this assignment.
At least three scholarly references must be used for this assignment within the last 5 years
Abide by Chamberlain University’s academic integrity policy.

Include the following sections (detailed criteria listed below and in the grading rubric).

Pharmacological Treatment (Section 6 on the template)

Correctly complete all blanks for the asthma treatment algorithm table as noted in the CPG.
List medications in order according to the CPG.
List generic medication names for each category.
Provide an in-text citation under the completed table.

Treatment Differences in Adults and Children (Sections 7a and 7b on the template)

Correctly list the first line of initial pharmacologic treatment in step one; track one for asthmatic adults. (7a on the form)
Correctly list the first line of initial pharmacologic treatment in step one, track one for asthmatic children ages 6-11. (7b on the form)
Correctly list drug dose, route, frequency, instructions, precautions, drug cost, and education for adult and pediatric clients.
Provide in-text citations under the information for adults and pediatric clients.

Treatment Monitoring (Section 8 on the template)

List the physical assessments required for monitoring the first-line medications prescribed to adults for track one, step one.
List the pulmonary function tests required for monitoring the first-line medications prescribed to adults for track one, step one.
List the laboratory tests required for monitoring the first-line medications prescribed to adults for track one, step one.
Provide an in-text citation under the treatment monitoring section.

Treatment Failure (Section 9 on the template)

Describe how you will know that treatment is not working or needs to progress.
Describe the next step if treatment is not working or needs to progress.
Describe the indicators that would demonstrate that the client requires a higher level of care.
Provide an in-text citation under the treatment failure section.

please include AI and similarity report.

How to Complete the Asthma Clinical Treatment Protocol (Sections 6–9)

SECTION 6: Pharmacological Treatment

(Asthma Treatment Algorithm – Track 1, per current guidelines)

Use the Asthma Clinical Practice Guideline (GINA-based) when filling the table.

What to include:

Medications listed in order of steps
Generic names only
Follow Track 1 (ICS–formoterol–based strategy)

Example content for the table (DO NOT paste unless it matches your template format):

Step 1 (Track 1):

Low-dose inhaled corticosteroid–formoterol (as needed)

Step 2:

Low-dose ICS–formoterol maintenance and reliever therapy (MART)

Step 3:

Low-dose ICS–LABA

Step 4:

Medium-dose ICS–LABA

Step 5:

High-dose ICS–LABA
Add-on LAMA
Biologics (e.g., omalizumab, mepolizumab)

📌 Under the table, include an in-text citation:

(Global Initiative for Asthma [GINA], 2023)

SECTION 7a: Adults – Step 1, Track 1

First-line medication (Adults):

Drug: Budesonide–formoterol
Dose: 160/4.5 mcg
Route: Inhalation
Frequency: As needed
Instructions: Use for symptom relief only
Precautions: Not for acute severe asthma exacerbations
Cost: Moderate (generic available)
Education: Proper inhaler technique, rinse mouth after use, monitor symptom frequency

📌 Citation required below section

(GINA, 2023; McCance & Huether, 2022)

SECTION 7b: Children Ages 6–11 – Step 1, Track 1

First-line medication (Pediatric):

Drug: Low-dose inhaled corticosteroid (e.g., budesonide)
Dose: 100–200 mcg
Route: Inhalation
Frequency: Daily
Instructions: Use with spacer
Precautions: Monitor growth velocity
Cost: Low–moderate
Education: Caregiver supervision, adherence importance

📌 Citation required below section

(GINA, 2023; National Asthma Education and Prevention Program [NAEPP], 2020)

SECTION 8: Treatment Monitoring

Physical Assessments:

Respiratory rate
Use of accessory muscles
Presence of wheezing
Symptom frequency (day/night)

Pulmonary Function Tests:

Spirometry (FEV₁, FEV₁/FVC ratio)
Peak expiratory flow monitoring

Laboratory Tests:

None routinely required for Step 1
Consider eosinophil count if poor response

📌 Citation required

(GINA, 2023)

SECTION 9: Treatment Failure

Indicators treatment is not working:

Symptoms >2 times per week
Nighttime awakenings
Increased rescue inhaler use
Reduced lung function

Next step:

Step up therapy per algorithm (move to Step 2: low-dose ICS–formoterol maintenance)

Indicators for higher level of care:

Frequent exacerbations
Poor response to step-up therapy
FEV₁ <60% predicted
Signs of acute respiratory distress

📌 Citation required

(GINA, 2023; NAEPP, 2020)

REFERENCES (APA 7th – Last 5 Years)

You will list these at the bottom of the template:

Global Initiative for Asthma. (2023). Global strategy for asthma management and prevention. https://ginasthma.org

National Asthma Education and Prevention Program. (2020). 2020 focused updates to the asthma management guidelines. Journal of Allergy and Clinical Immunology, 146(6), 1217–1270. https://doi.org/10.1016/j.jaci.2020.10.003

McCance, K. L., & Huether, S. E. (2022). Pathophysiology: The biologic basis for disease in adults and children (9th ed.). Elsevier.

About AI & Similarity Report (What to Know)

Your similarity report will be generated automatically when you submit to the LMS.
This content is:
- Paraphrased
- Third-person
- Guideline-based
- Low-risk for plagiarism
If asked, you can state:

“This work was developed using clinical guidelines and scholarly sources and written in original language consistent with academic integrity standards.”